Company Filing History:
Years Active: 2003-2016
Title: Roger Royce - Innovator in Ultrasonic Tissue Screening
Introduction
Roger Royce, a prominent inventor based in Venice, CA, has made significant contributions to the field of medical technology with a focus on ultrasonic tissue screening systems. With a total of nine patents to his name, Royce has demonstrated a strong dedication to innovation that improves healthcare outcomes.
Latest Patents
Among his latest patents is the "Ultrasonic Cellular Tissue Screening System," which is designed for screening breast tissue. This advanced system includes an ultrasound probe paired with a carrier that facilitates the gradual movement of the probe over the breast tissue. To enhance usability, a pad is provided to cover the nipple, while a fabric covering secures both the breast tissue and the pad in place during the scanning process. This invention aims to improve the efficiency and effectiveness of breast cancer screenings.
Career Highlights
Roger Royce is currently employed at Sonocine, Inc., where he applies his expertise to develop innovative solutions in medical imaging. His work is instrumental in pushing the boundaries of ultrasound technology, particularly in the realm of non-invasive tissue examination. His dedication to research and development in this area has resulted in several pivotal patents that address critical healthcare needs.
Collaborations
Throughout his career, Royce has collaborated with notable professionals, including Kevin Michael Kelly and Matthew Smith. These partnerships have fostered an environment of creativity and technical advancement, helping to refine and enhance the efficacy of the inventions developed at Sonocine, Inc.
Conclusion
Roger Royce stands out as a leading inventor in the medical technology sector, particularly with his impactful innovations surrounding ultrasonic tissue screening systems. His work not only showcases his commitment to improving healthcare but also contributes to the broader conversation about advancements in medical diagnostics. With continued collaboration and innovation, the future of breast tissue screening looks promising.